Oct 5 (Reuters) - AbbVie Inc (NYSE:ABBV) ABBV.N :
* ABBVIE RECEIVES HEALTH CANADA APPROVAL OF ORILISSA™ (ELAGOLIX) FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS
* ABBVIE CANADA - ORILISSA IS EXPECTED TO BE AVAILABLE IN CANADIAN RETAIL PHARMACIES IN EARLY NOVEMBER 2018